Skip to main content

Table 1 Baseline characteristics of healthy donors and CRC patients from the Colonomics study

From: Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer

Healthy donors (n = 50)

Gender

 

 Male

27 (54 %)

 Female

23 (46 %)

Median age (years, range)

63 (25–88)

Site

 

 Right

27 (54 %)

 Left

23 (46 %)

Cases (n = 98)

 

Gender

 

 Male

71 (72.4 %)

 Female

27 (27.6 %)

Median age (years, range)

71 (43–87)

Site

 

 Right

38 (38.8 %)

 Left

60 (61.2 %)

Stage

 

 II A

90 (91.8 %)

 II B

8 (8.2 %)

Recurrence

 

 No relapse

76 (77.6 %)

 Relapse

22 (22.4 %)

Follow-up, median time (months, range)

67.8 (24.8–136.9)